Small intestinal bacterial overgrowth syndrome (SIBO)
Clinical trials for Small intestinal bacterial overgrowth syndrome (SIBO) explained in plain language.
Never miss a new study
Get alerted when new Small intestinal bacterial overgrowth syndrome (SIBO) trials appear
Sign up with your email to follow new studies for Small intestinal bacterial overgrowth syndrome (SIBO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a probiotic yeast rival antibiotics for gut bloating and diarrhea?
Disease control Not yet recruitingResearchers are testing whether a probiotic yeast, Saccharomyces boulardii, works as well as the antibiotic rifaximin for adults with small intestinal bacterial overgrowth (SIBO) who have bloating and diarrhea. The trial enrolls 222 people aged 18 to 70 with a positive breath tes…
Matched conditions: SMALL INTESTINAL BACTERIAL OVERGROWTH SYNDROME (SIBO)
Phase 4 • Sponsor: Shandong University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Herbal capsules take on gut bacteria: a new hope for IBS?
Disease control Not yet recruitingThis pilot study tests whether an herbal supplement called Biocidin REMOVE can clear small intestinal bacterial overgrowth (SIBO) in adults with irritable bowel syndrome (IBS). SIBO involves an overgrowth of bacteria in the small intestine, which can worsen IBS symptoms. About 40…
Matched conditions: SMALL INTESTINAL BACTERIAL OVERGROWTH SYNDROME (SIBO)
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could probiotics help antibiotics work better for gut bacteria overgrowth?
Disease control Not yet recruitingThis study looks at whether adding a specific probiotic (containing Enterococcus faecium and Bacillus subtilis) to the antibiotic rifaximin can improve treatment for small intestinal bacterial overgrowth (SIBO), a condition that causes bloating, pain, and diarrhea. About 100 adul…
Matched conditions: SMALL INTESTINAL BACTERIAL OVERGROWTH SYNDROME (SIBO)
Phase 4 • Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC